1 – 39 of 39
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer
(
- Contribution to journal › Article
-
Mark
Protection of Kidney Function with Human Antioxidation Protein α
1
-Microglobulin in a Mouse
177
Lu-DOTATATE Radiation Therapy Model
(
- Contribution to journal › Article
-
Mark
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
(
- Contribution to journal › Article
-
Mark
Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux
(
- Contribution to journal › Article
- 2018
-
Mark
Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free Cu-Labeled Nanoparticles
(
- Contribution to journal › Article
-
Mark
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Combined Magnetomotive ultrasound, PET/CT, and MR imaging of (68)Ga-labelled superparamagnetic iron oxide nanoparticles in rat sentinel lymph nodes in vivo
(
- Contribution to journal › Article
-
Mark
An attenuation method for reducing count rate losses in preclinical PET during intratherapeutic imaging
2017) 2016 IEEE Nuclear Science Symposium, Medical Imaging Conference and Room-Temperature Semiconductor Detector Workshop, NSS/MIC/RTSD 2016 2017-January.(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Applications and characterization of radiolabeled or magnetizable nano- and microparticles for res, lymph, and blood flow studies
2017) p.193-227(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities.
(
- Contribution to journal › Scientific review
-
Mark
Count rate characteristics and image distortion in preclinical PET systems during intratherapeutic radiopharmaceutical therapy imaging
(
- Contribution to journal › Article
-
Mark
High resolution digital autoradiographic and dosimetric analysis of heterogeneous radioactivity distribution in xenografted prostate tumors
(
- Contribution to journal › Article
-
Mark
Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays
(
- Contribution to journal › Article
-
Mark
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
(
- Contribution to journal › Article
-
Mark
Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
(
- Contribution to journal › Article
-
Mark
Effects of high photon fluence rate from therapeutic radionuclides on preclinical and clinical PET systems
2016) IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014 In 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2015
-
Mark
Biodistribution and pharmacokinetics of recombinant α1-microglobulin and its potential use in radioprotection of kidneys.
(
- Contribution to journal › Article
-
Mark
Human Anti-Oxidation Protein A1M-A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy.
(
- Contribution to journal › Scientific review
-
Mark
Characterization of a double-sided silicon strip detector autoradiography system.
(
- Contribution to journal › Article
-
Mark
Using Rose's metal alloy as a pinhole collimator material in preclinical small-animal imaging: A Monte Carlo evaluation.
(
- Contribution to journal › Article
-
Mark
Intratherapeutic Biokinetic Measurements, Dosimetry Parameters Estimate, and Monitoring Treatment Efficacy using Cerenkov Luminescence Imaging in Preclinical Radionuclide Therapy.
(
- Contribution to journal › Article
-
Mark
Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.
(
- Contribution to journal › Article
-
Mark
Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution.
(
- Contribution to journal › Article
-
Mark
Size-dependent lymphatic uptake of nanoscale-tailored particles as tumor mass increases
(
- Contribution to journal › Article
-
Mark
Superparamagnetic iron oxide nanoparticles as a multimodal contrast agent for up to five imaging modalities
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a In-111-radiolabelled monoclonal antibody, 11B6
(
- Contribution to journal › Article
-
Mark
Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein.
(
- Contribution to journal › Article
-
Mark
A solid target system with remote handling of irradiated targets for PET cyclotrons.
(
- Contribution to journal › Article
-
Mark
Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma.
(
- Contribution to journal › Article
-
Mark
A small-scale anatomical dosimetry model of the liver.
(
- Contribution to journal › Article
-
Mark
Testis dosimetry in individual patients by combining a small-scale dosimetry model and pharmacokinetic modeling-application of (111)In-Ibritumomab Tiuxetan (Zevalin(®)).
(
- Contribution to journal › Article
-
Mark
Optimizing retention of multimodal imaging nanostructures in sentinel lymph nodes by nanoscale size tailoring.
(
- Contribution to journal › Article
-
Mark
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.
(
- Contribution to journal › Article
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842(
- Contribution to journal › Article
- 2013
-
Mark
The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model.
(
- Contribution to journal › Article
- 2012
-
Mark
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
(
- Contribution to journal › Article
-
Mark
Use of Monte Carlo simulations with a realistic rat phantom for examining the correlation between hematopoietic system response and red marrow absorbed dose in Brown Norway rats undergoing radionuclide therapy with (177)Lu- and (90)Y-BR96 mAbs.
(
- Contribution to journal › Article
-
Mark
Photon activation therapy of RG2 glioma carrying Fischer rats using stable thallium and monochromatic synchrotron radiation.
(
- Contribution to journal › Article
- 2011
-
Mark
Dosimetry in patients with B-cell lymphoma treated with [90Y]ibritumomab tiuxetan or [131I]tositumomab.
(
- Contribution to journal › Article